SK Chemical won the second trial over the Norvatis’s dementia patch treatment

Published: 2014-11-11 11:33:22

Updated: 2014-11-11 11:34:13

As SK Chemical won the patent war over dementia patch treatment,its position has been significantly stable in the market

The Patent Court decided to take the side of the requesting company, SK Chemical, in the appellate trial of patent nullity related to the Norvatis’s dementia patch treatment ‘Exelon Patch(Rivastigmine)’ on the 8^th.

In the late 2012, Norvatis filed a lawsuit against SK Chemi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.